Vista Pharmaceuticals Ltd. Financials

NSE BSE

16:01 Jul 18

Vista Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

11.10

-0.22 (-1.94%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

11.10

-0.22 (-1.94%)
16:01 Jul 18

Quality

0/100
Not Eligible

Valuation

15/100
Expensive Valuation

Technical

56/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	1.27	0.39	1	10.29	10.07
Operating Expenses +	2.99	1.6	5.45	13.86	14.1
Raw Material	0.73	0.37	2.83	8.88	7.9
Increase Decrease in Cost	0	0	0	0.01	0.45
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1.15	0.57	0.51	1.79	2
Miscellaneous Expenses	1.11	0.66	2.11	3.18	3.75
Operating Profit	-1.72	-1.21	-4.45	-3.57	-4.03
Other Income	0.32	0.17	0.4	0.33	0.44
Depreciation	0.73	0.62	0.62	0.72	0.74
Interest	1.55	0.9	1.21	1.22	0.96
Profit before tax and exceptio..	-3.69	-2.56	-5.88	-5.18	-5.29
Exceptional Items	0	0	0	0	0
PBT	-3.69	-2.56	-5.88	-5.18	-5.29
Provision for Taxation	-1.8	-1.73	-0.21	-0.67	-0.64
Net Profit	-1.89	-0.83	-5.66	-4.51	-4.65
NET Profit after MI	0	0	0	0	0
EPS	-0.54	-0.24	-1.54	-1.03	-0.79
Operating Profit Margin (%)	-135.43	-310.26	-445	-34.69	-40.02
Net Profit Margin (%)	-148.82	-212.82	-566	-43.83	-46.18

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	21.20	21.20	21.20	21.20	21.20
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: